EZH2 and leukemia: Moreover, neither expression of Plag1 nor Lin28b was significantly altered following GSK343 treatment of MLL-AF9 tumors, reinforcing the concept of disparity between transcriptional programs repressed by Ezh2 that are responsible for early tumor suppression and later maintenance of these leukemias.